West Pharmaceutical Services Inc (WST) stock
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3027% above fair value
$396.69−7.33 (-1.81%)
Close on Nov 19, 2026Market cap $27.63BP/E 44.5Yield 0.22%
West Pharmaceutical Services free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
West Pharmaceutical Services's free cash flow for the twelve months ending Sep 30, 2026 was $453.40M, up 19.6% year over year. For fiscal 2025 it was $468.90M, up 69.6% from the year before. Over ten years it grew 19.2% a year on average. The highest annual figure on record is $468.90M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $468.90M | +69.6% |
| FY2024 | Dec 31, 2024 | $276.40M | -33.3% |
| FY2023 | Dec 31, 2023 | $414.50M | -5.7% |
| FY2022 | Dec 31, 2022 | $439.40M | +32.9% |
| FY2021 | Dec 31, 2021 | $330.60M | +10.9% |
| FY2020 | Dec 31, 2020 | $298.10M | +23.8% |
| FY2019 | Dec 31, 2019 | $240.80M | +30.9% |
| FY2018 | Dec 31, 2018 | $183.90M | +38.8% |
| FY2017 | Dec 31, 2017 | $132.50M | +169.3% |
| FY2016 | Dec 31, 2016 | $49.20M | -39.1% |
| FY2015 | Dec 31, 2015 | $80.80M | +13.8% |
| FY2014 | Dec 31, 2014 | $71.00M | +3.5% |
| FY2013 | Dec 31, 2013 | $68.60M | +22.3% |
| FY2012 | Dec 31, 2012 | $56.10M | +58.9% |
| FY2011 | Dec 31, 2011 | $35.30M | -47.5% |
| FY2010 | Dec 31, 2010 | $67.20M | +104.9% |
| FY2009 | Dec 31, 2009 | $32.80M | – |
| FY2008 | Dec 31, 2008 | -$3.60M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $150.40M | +12.3% |
| Q2 FY2026 | Jun 30, 2026 | $80.80M | -20.7% |
| Q1 FY2026 | Mar 31, 2026 | $47.20M | -18.8% |
| Q4 FY2025 | Dec 31, 2025 | $175.00M | +105.4% |
| Q3 FY2025 | Sep 30, 2025 | $133.90M | +35.5% |
| Q2 FY2025 | Jun 30, 2025 | $101.90M | +57.3% |
| Q1 FY2025 | Mar 31, 2025 | $58.10M | +110.5% |
| Q4 FY2024 | Dec 31, 2024 | $85.20M | -34.7% |
| Q3 FY2024 | Sep 30, 2024 | $98.80M | -26.4% |
| Q2 FY2024 | Jun 30, 2024 | $64.80M | -30.9% |
| Q1 FY2024 | Mar 31, 2024 | $27.60M | -50.7% |
| Q4 FY2023 | Dec 31, 2023 | $130.40M | -4.0% |
| Q3 FY2023 | Sep 30, 2023 | $134.30M | +20.9% |
| Q2 FY2023 | Jun 30, 2023 | $93.80M | -12.3% |
| Q1 FY2023 | Mar 31, 2023 | $56.00M | -34.4% |
| Q4 FY2022 | Dec 31, 2022 | $135.90M | +61.2% |
| Q3 FY2022 | Sep 30, 2022 | $111.10M | -11.0% |
| Q2 FY2022 | Jun 30, 2022 | $107.00M | +22.3% |
| Q1 FY2022 | Mar 31, 2022 | $85.40M | +151.2% |
| Q4 FY2021 | Dec 31, 2021 | $84.30M | -7.4% |
| Q3 FY2021 | Sep 30, 2021 | $124.80M | +75.5% |
| Q2 FY2021 | Jun 30, 2021 | $87.50M | -21.2% |
| Q1 FY2021 | Mar 31, 2021 | $34.00M | +36.0% |
| Q4 FY2020 | Dec 31, 2020 | $91.00M | +32.3% |
| Q3 FY2020 | Sep 30, 2020 | $71.10M | -6.9% |
| Q2 FY2020 | Jun 30, 2020 | $111.00M | +44.5% |
| Q1 FY2020 | Mar 31, 2020 | $25.00M | +33.0% |
| Q4 FY2019 | Dec 31, 2019 | $68.80M | +59.3% |
| Q3 FY2019 | Sep 30, 2019 | $76.40M | +23.4% |
| Q2 FY2019 | Jun 30, 2019 | $76.80M | +24.3% |
| Q1 FY2019 | Mar 31, 2019 | $18.80M | +10.6% |
| Q4 FY2018 | Dec 31, 2018 | $43.20M | -16.9% |
| Q3 FY2018 | Sep 30, 2018 | $61.90M | +49.2% |
| Q2 FY2018 | Jun 30, 2018 | $61.80M | +10.8% |
| Q1 FY2018 | Mar 31, 2018 | $17.00M | – |
| Q4 FY2017 | Dec 31, 2017 | $52.00M | +114.0% |
| Q3 FY2017 | Sep 30, 2017 | $41.50M | – |
| Q2 FY2017 | Jun 30, 2017 | $55.80M | – |
| Q1 FY2017 | Mar 31, 2017 | -$16.80M | – |
| Q4 FY2016 | Dec 31, 2016 | $24.30M | – |
See a number that looks wrong?